ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2024 · 33 positions · Total reported value $118.74M · Top-10 concentration 65.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 33 equity positions with a combined reported value of $118.74M. The filing implies a focused portfolio: its ten largest positions account for 65.3% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were OCUL ($18.95M), ELVN ($9.29M), PCVX ($8.34M). By sector, the heaviest allocations are Health Care 83.5%, Other 16.5%. Versus the prior quarter, allocation shifted toward Health Care (+7.2pp) and away from Other (-7.2pp).

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 57% of names.

The largest new positions opened in Q2 2024 were CRBP ($2.92M), HLXB ($1.82M), ARGX ($1.72M).

Of the 8 positions fully exited versus the prior quarter, the largest were APLT ($5.39M), IRON ($4.78M), CLDX ($4.57M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • CRBP CORBUS PHARMACEUTICALS HLDGS · $2.92M
  • HLXB HELIX ACQUISITION CORP II · $1.82M
  • ARGX ARGENX SE · $1.72M
  • TRVI TREVI THERAPEUTICS INC · $774.80K
  • CELC CELCUITY INC · $737.10K
  • PLRX PLIANT THERAPEUTICS INC · $496.65K
  • RAPP RAPPORT THERAPEUTICS INC · $465.20K
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $432.23K

Fully Exited (vs previous quarter)

  • APLT APPLIED THERAPEUTICS INC · prev qtr: $5.39M
  • IRON DISC MEDICINE INC · prev qtr: $4.78M
  • CLDX CELLDEX THERAPEUTICS INC NEW · prev qtr: $4.57M
  • HLVX HILLEVAX INC · prev qtr: $4.17M
  • IMVT IMMUNOVANT INC · prev qtr: $2.98M
  • VSTM VERASTEM INC · prev qtr: $2.44M
  • LYRA LYRA THERAPEUTICS INC · prev qtr: $1.08M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $933.80K

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.5%
Other 16.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.77M $18.95M 15.96%
15.96%
Add
2 397.70K $9.29M 7.83%
7.83%
Hold
3 110.40K $8.34M 7.02%
7.02%
Add
4 212.50K $7.50M 6.32%
6.32%
Add
5 164.43K $6.80M 5.73%
5.73%
Add
6 135.14K $6.05M 5.10%
5.10%
Add
7 250.37K $5.39M 4.54%
4.54%
Reduce
8 2.33M $5.22M 4.40%
4.40%
Reduce
9 133.00K $5.16M 4.35%
4.35%
Reduce
10 72.10K $4.83M 4.07%
4.07%
Add
11 27.50K $4.34M 3.66%
3.66%
Reduce
12 269.61K $3.47M 2.92%
2.92%
Add
13 78.70K $3.39M 2.86%
2.86%
Add
14 163.00K $3.36M 2.83%
2.83%
Add
15 1.66M $3.34M 2.81%
2.81%
Reduce
16 64.50K $2.92M 2.46%
2.46%
New
17 1.85M $2.70M 2.27%
2.27%
Hold
18 199.43K $2.59M 2.19%
2.19%
Hold
19 369.28K $2.51M 2.12%
2.12%
Reduce
20 677.00K $2.44M 2.05%
2.05%
Add
21 42.20K $2.33M 1.96%
1.96%
Add
22 177.84K $1.82M 1.53%
1.53%
New
23 4.00K $1.72M 1.45%
1.45%
New
24 260.00K $774.80K 0.65%
0.65%
New
25 45.00K $737.10K 0.62%
0.62%
New
26 96.00K $678.72K 0.57%
0.57%
Reduce
27 46.20K $496.65K 0.42%
0.42%
New
28 20.00K $465.20K 0.39%
0.39%
New
29 22.50K $432.23K 0.36%
0.36%
New
30 195.00K $382.20K 0.32%
0.32%
Reduce
31 70.50K $176.25K 0.15%
0.15%
Reduce
32 250 $100.75K 0.09%
0.09%
New
33 90.83K $14.53K 0.01%
0.01%
Hold

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 33 equity positions worth $118.74M in aggregate; its largest disclosed positions were OCUL ($18.95M), ELVN ($9.29M), PCVX ($8.34M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $118.74M of long equity holdings across 33 positions as of 2024-Q2. Top-10 holdings account for 65.3% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →